FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3084341941> ?p ?o ?g. }

• W3084341941 endingPage "1596" @default.
• W3084341941 startingPage "1596" @default.
• W3084341941 abstract "Previous observational studies have suggested that fluoroquinolones are associated with aortic aneurysm or dissection, but these studies may be subject to confounding by indication or surveillance bias.To assess the association of fluoroquinolones with risk of aortic aneurysm or aortic dissection (AA/AD) while accounting for potential confounding by fluoroquinolone indication and bias owing to differential surveillance.In an observational cohort study using a US commercial claims database, 2 pairwise 1:1 propensity score-matched cohorts were identified: patients aged 50 years or older with a diagnosis of pneumonia 3 days or less before initiating treatment with a fluoroquinolone or azithromycin and patients aged 50 years or older with a urinary tract infection (UTI) diagnosis 3 days or less before initiating a fluoroquinolone or combined trimethoprim and sulfamethoxazole. Hazard ratios (HRs) and 95% CIs were estimated controlling for 85 baseline confounders. In a secondary analysis, patients receiving fluoroquinolones were compared with those receiving amoxicillin, both with and without considering baseline aortic imaging, to address differences in detection of AA/AD before antibiotic use. Data on patients within the database from January 1, 2003, through September 30, 2015, were analyzed. Data analysis was conducted from July 23, 2019, to July 6, 2020.Hospitalization for AA/AD occurring within 60 days following treatment initiation.After propensity score matching, patient characteristics were well balanced, with 279 554 patients (mean [SD] age, 63.66 [10.93] years; 149 976 women [53.6%]) in the pneumonia cohort and 948 364 patients (mean [SD] age, 62.06 [10.33] years; 823 667 women [86.9%]) in the UTI cohort. Initiators of fluoroquinolones (n = 139 772 pairs in the pneumonia cohort and n = 474 182 pairs in the UTI cohort) had an increased rate of AA/AD compared with initiators of azithromycin (HR, 2.57; 95% CI, 1.36-4.86; incidence, 0.03% for fluoroquinolones vs 0.01% for azithromycin) but no increased rate compared with initiators of combined trimethoprim and sulfamethoxazole (HR, 0.99; 95% CI, 0.62-1.57; incidence, <0.01% in both UTI groups). Secondary analysis using amoxicillin as a comparator (n = 3 976 162 pairs) produced results consistent with those from earlier studies (HR, 1.54; 95% CI, 1.33-1.79; incidence, <0.01% in both groups). Requiring baseline imaging in this cohort (n = 542 649 pairs) to address surveillance bias attenuated the increased rate (HR, 1.13; 95% CI, 0.96-1.33; incidence, 0.06% for fluoroquinolones vs 0.05% for amoxicillin).The findings of this nationwide cohort study of adults with pneumonia or UTI suggest an increased relative rate of AA/AD associated with fluoroquinolones within the pneumonia cohort but not within the UTI cohort. In both cohorts, the absolute rate of AA/AD appeared to be low (<0.1%). The increased relative rate observed in the pneumonia cohort may be due to residual confounding or surveillance bias." @default.
• W3084341941 created "2020-09-14" @default.
• W3084341941 creator A5045018128 @default.
• W3084341941 creator A5059157113 @default.
• W3084341941 creator A5065580650 @default.
• W3084341941 creator A5083832003 @default.
• W3084341941 creator A5084185195 @default.
• W3084341941 creator A5089776227 @default.
• W3084341941 date "2020-12-01" @default.
• W3084341941 modified "2023-10-03" @default.
• W3084341941 title "Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection" @default.
• W3084341941 cites W1964098393 @default.
• W3084341941 cites W1967862917 @default.
• W3084341941 cites W1986811480 @default.
• W3084341941 cites W1988579079 @default.
• W3084341941 cites W2011339859 @default.
• W3084341941 cites W2084036158 @default.
• W3084341941 cites W2087018232 @default.
• W3084341941 cites W2116787565 @default.
• W3084341941 cites W2125048378 @default.
• W3084341941 cites W2126049444 @default.
• W3084341941 cites W2141008245 @default.
• W3084341941 cites W2205625699 @default.
• W3084341941 cites W2589095047 @default.
• W3084341941 cites W2789296879 @default.
• W3084341941 cites W2792459321 @default.
• W3084341941 cites W2803691265 @default.
• W3084341941 cites W2883094343 @default.
• W3084341941 cites W2890856452 @default.
• W3084341941 cites W2944508663 @default.
• W3084341941 cites W3004550269 @default.
• W3084341941 cites W4205594235 @default.
• W3084341941 cites W4230866161 @default.
• W3084341941 cites W4233044260 @default.
• W3084341941 cites W4297900878 @default.
• W3084341941 doi "https://doi.org/10.1001/jamainternmed.2020.4199" @default.
• W3084341941 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7489402" @default.
• W3084341941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32897307" @default.
• W3084341941 hasPublicationYear "2020" @default.
• W3084341941 type Work @default.
• W3084341941 sameAs 3084341941 @default.
• W3084341941 citedByCount "38" @default.
• W3084341941 countsByYear W30843419412021 @default.
• W3084341941 countsByYear W30843419412022 @default.
• W3084341941 countsByYear W30843419412023 @default.
• W3084341941 crossrefType "journal-article" @default.
• W3084341941 hasAuthorship W3084341941A5045018128 @default.
• W3084341941 hasAuthorship W3084341941A5059157113 @default.
• W3084341941 hasAuthorship W3084341941A5065580650 @default.
• W3084341941 hasAuthorship W3084341941A5083832003 @default.
• W3084341941 hasAuthorship W3084341941A5084185195 @default.
• W3084341941 hasAuthorship W3084341941A5089776227 @default.
• W3084341941 hasBestOaLocation W30843419411 @default.
• W3084341941 hasConcept C126322002 @default.
• W3084341941 hasConcept C141071460 @default.
• W3084341941 hasConcept C17923572 @default.
• W3084341941 hasConcept C201903717 @default.
• W3084341941 hasConcept C207103383 @default.
• W3084341941 hasConcept C2776098176 @default.
• W3084341941 hasConcept C2777323849 @default.
• W3084341941 hasConcept C2777914695 @default.
• W3084341941 hasConcept C2779980429 @default.
• W3084341941 hasConcept C2779993142 @default.
• W3084341941 hasConcept C44249647 @default.
• W3084341941 hasConcept C71924100 @default.
• W3084341941 hasConcept C72563966 @default.
• W3084341941 hasConcept C77350462 @default.
• W3084341941 hasConceptScore W3084341941C126322002 @default.
• W3084341941 hasConceptScore W3084341941C141071460 @default.
• W3084341941 hasConceptScore W3084341941C17923572 @default.
• W3084341941 hasConceptScore W3084341941C201903717 @default.
• W3084341941 hasConceptScore W3084341941C207103383 @default.
• W3084341941 hasConceptScore W3084341941C2776098176 @default.
• W3084341941 hasConceptScore W3084341941C2777323849 @default.
• W3084341941 hasConceptScore W3084341941C2777914695 @default.
• W3084341941 hasConceptScore W3084341941C2779980429 @default.
• W3084341941 hasConceptScore W3084341941C2779993142 @default.
• W3084341941 hasConceptScore W3084341941C44249647 @default.
• W3084341941 hasConceptScore W3084341941C71924100 @default.
• W3084341941 hasConceptScore W3084341941C72563966 @default.
• W3084341941 hasConceptScore W3084341941C77350462 @default.
• W3084341941 hasIssue "12" @default.
• W3084341941 hasLocation W30843419411 @default.
• W3084341941 hasLocation W30843419412 @default.
• W3084341941 hasLocation W30843419413 @default.
• W3084341941 hasOpenAccess W3084341941 @default.
• W3084341941 hasPrimaryLocation W30843419411 @default.
• W3084341941 hasRelatedWork W1964182391 @default.
• W3084341941 hasRelatedWork W1995982834 @default.
• W3084341941 hasRelatedWork W2022044594 @default.
• W3084341941 hasRelatedWork W2098571791 @default.
• W3084341941 hasRelatedWork W2109333892 @default.
• W3084341941 hasRelatedWork W2557114555 @default.
• W3084341941 hasRelatedWork W2919644205 @default.
• W3084341941 hasRelatedWork W2980733144 @default.
• W3084341941 hasRelatedWork W2980864243 @default.
• W3084341941 hasRelatedWork W3195162008 @default.
• W3084341941 hasVolume "180" @default.

• next